Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
MSGS typically reports before market open, meaning Day 0 captures the first full trading session reaction to results, while Day +1 reflects follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-05-08 | -$2.39 (-0.72%) | $13.74 (4.13%) | +$13.99 (+4.24%) | $16.47 (4.99%) |
| 2026-02-05 | -$13.60 (-4.73%) | $33.41 (11.63%) | +$5.64 (+2.06%) | $6.07 (2.22%) |
| 2025-10-31 | -$10.38 (-4.62%) | $10.79 (4.80%) | +$2.54 (+1.18%) | $11.83 (5.52%) |
| 2025-08-12 | -$7.08 (-3.50%) | $11.31 (5.59%) | -$0.88 (-0.45%) | $6.91 (3.54%) |
| 2025-05-02 | -$5.49 (-2.85%) | $7.96 (4.12%) | +$1.51 (+0.81%) | $4.98 (2.66%) |
| 2025-02-04 | -$7.83 (-3.59%) | $10.22 (4.68%) | -$1.58 (-0.75%) | $4.26 (2.02%) |
| 2024-11-01 | -$1.71 (-0.77%) | $12.24 (5.50%) | -$5.11 (-2.31%) | $7.41 (3.35%) |
| 2024-08-13 | -$1.02 (-0.52%) | $19.27 (9.84%) | +$2.09 (+1.07%) | $2.69 (1.38%) |
| Avg Abs Move | 2.66% | 6.29% | 1.61% | 3.21% |
Historical price behavior shows moderate volatility around earnings releases, with the stock averaging a 2.66% absolute move on Day 0 and a 6.29% intraday range. Day +1 follow-through averages 1.61% with a 3.21% range, indicating that initial reactions tend to be larger than subsequent sessions.
The most recent earnings (May 2026) saw relatively muted Day 0 action with a -0.72% move and 4.13% range, followed by a stronger +4.24% rally on Day +1 as investors digested the results. In contrast, the February 2026 report triggered a sharp -4.73% Day 0 decline with an 11.63% intraday range — the largest swing in the dataset — before stabilizing with a +2.06% recovery on Day +1.
The pattern suggests MSGS tends to see initial selling pressure on earnings day (five of eight reports showed Day 0 declines), but often recovers in the following session. The wide variation in Day 0 ranges — from 4.13% to 11.63% — reflects the market's difficulty pricing in the company's volatile results. Investors should prepare for potential intraday swings exceeding 6% regardless of the initial direction.
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 9) |
| Expected Move | $17.48 (4.22%) |
| Expected Range | $396.64 to $431.60 |
| Implied Volatility | 36.07% |
The options market is pricing a 4.22% expected move ($17.48 range between $396.64 and $431.60) for the August 21 expiration, which is moderately below the stock's average historical Day 0 move of 6.29% but above the average absolute Day 0 move of 2.66%. This suggests options traders are anticipating volatility in line with typical earnings reactions, though not as extreme as the February 2026 event that saw an 11.63% intraday range.
Analysts maintain a bullish stance on MSGS with an average rating of 3.78 (between Hold and Buy) and a mean price target of $441.17, implying 6.5% upside from the current price of $414.12. The consensus includes 4 Strong Buys, 1 Moderate Buy, 3 Holds, and 1 Strong Sell, with price targets ranging from $360.00 to $522.00.
Sentiment has deteriorated over the past month, with the average recommendation slipping from 3.89 to 3.78. The shift reflects one analyst downgrading from Hold to Strong Sell and another moving from Hold to Moderate Buy, resulting in a more polarized view. One month ago, the consensus showed 4 Strong Buys and 5 Holds with no sell ratings; today's breakdown includes the first Strong Sell rating in recent months.
Despite the slight deterioration, the analyst community remains predominantly positive, with 5 of 9 analysts (56%) rating the stock a buy or better. The $441.17 mean target sits comfortably above the current price, though it's worth noting the wide target range reflects significant disagreement about valuation. The high estimate of $522.00 implies 26% upside, while the low estimate of $360.00 suggests 13% downside risk — a spread that underscores the uncertainty surrounding the company's earnings trajectory and ability to sustain profitability beyond playoff-driven quarters.
MSGS enters earnings with strong technical momentum, trading at $414.12 and positioned above all major moving averages. The stock sits above its 5-day ($396.20), 10-day ($395.09), 20-day ($395.55), 50-day ($388.80), 100-day ($362.65), and 200-day ($313.54) moving averages, indicating a well-established uptrend across all timeframes.
The Barchart Technical Opinion currently shows a 100% Buy signal, strengthening from 80% Buy last week and matching the 100% Buy reading from a month ago. This improvement reflects the stock's recent breakout to new highs and sustained momentum above key technical levels.
Timeframe Analysis:
Trend Characteristics: The Maximum strength rating combined with the Strongest direction signal indicates MSGS is in an exceptionally robust uptrend with powerful momentum across all timeframes heading into earnings.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $396.20 | 50-Day MA | $388.80 |
| 10-Day MA | $395.09 | 100-Day MA | $362.65 |
| 20-Day MA | $395.55 | 200-Day MA | $313.54 |
The technical setup is highly supportive heading into earnings, with the stock trading at $414.12 — well above all moving averages and near recent highs around $411.73. The 32% premium to the 200-day moving average ($313.54) and the tight clustering of shorter-term averages ($395-$397) suggest strong support in the $395-$400 zone if results disappoint. However, the extended nature of the rally also means the stock has limited cushion for a miss, with the options market pricing a potential move down to $396.64. Key resistance sits at the 52-week high of $411.73, already breached in today's session, with the next technical target at the $431.60 level implied by the options expected move. The uniformly bullish technical signals across all timeframes suggest momentum traders are positioned for a positive outcome, which could amplify volatility if results fail to meet the elevated $0.78 EPS estimate.